<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: Woodcock Cites a &#8220;Turning Point&#8221; in Drug Development</title>
	<atom:link href="http://blog.pharmtech.com/2011/07/18/woodcock-cites-a-turning-point-in-drug-development/feed/" rel="self" type="application/rss+xml" />
	<link>http://blog.pharmtech.com/2011/07/18/woodcock-cites-a-turning-point-in-drug-development/</link>
	<description>The blog of Pharmaceutical Technology magazine</description>
	<lastBuildDate>Thu, 09 May 2013 23:30:55 -0400</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.4</generator>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
		<item>
		<title>By: George Zorbas</title>
		<link>http://blog.pharmtech.com/2011/07/18/woodcock-cites-a-turning-point-in-drug-development/comment-page-1/#comment-39253</link>
		<dc:creator>George Zorbas</dc:creator>
		<pubDate>Sun, 24 Jul 2011 21:18:34 +0000</pubDate>
		<guid isPermaLink="false">http://blog.pharmtech.com/?p=4421#comment-39253</guid>
		<description>Erik,
I certainly hope you are right.
A cautionary note before we announce, prematurely, that pharma&#039;s R&amp;D problems have been solved. The approval of NME&#039;s is the results of many years of basic research and development. 
1. Is it possible that this may be an unusual confluence of NME 
    approvals, and nothing more than a bumper crop year?
2. Don&#039;t we need to see this trend continue for a decade or more in
    order to say with certainty that we have turned the corner on the
    R&amp;D drought of the pharma industry? One year does not make a
    trend.
This is hopeful, and we will have to see what future years bring.</description>
		<content:encoded><![CDATA[<p>Erik,<br />
I certainly hope you are right.<br />
A cautionary note before we announce, prematurely, that pharma&#8217;s R&amp;D problems have been solved. The approval of NME&#8217;s is the results of many years of basic research and development.<br />
1. Is it possible that this may be an unusual confluence of NME<br />
    approvals, and nothing more than a bumper crop year?<br />
2. Don&#8217;t we need to see this trend continue for a decade or more in<br />
    order to say with certainty that we have turned the corner on the<br />
    R&amp;D drought of the pharma industry? One year does not make a<br />
    trend.<br />
This is hopeful, and we will have to see what future years bring.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Desiree Ng</title>
		<link>http://blog.pharmtech.com/2011/07/18/woodcock-cites-a-turning-point-in-drug-development/comment-page-1/#comment-39153</link>
		<dc:creator>Desiree Ng</dc:creator>
		<pubDate>Thu, 21 Jul 2011 13:49:46 +0000</pubDate>
		<guid isPermaLink="false">http://blog.pharmtech.com/?p=4421#comment-39153</guid>
		<description>Is there any way to include way to email article to friend? You have some specific articles that I&#039;d like to email to myself to have on file. Thanks in advance for your help.</description>
		<content:encoded><![CDATA[<p>Is there any way to include way to email article to friend? You have some specific articles that I&#8217;d like to email to myself to have on file. Thanks in advance for your help.</p>
]]></content:encoded>
	</item>
</channel>
</rss>
